Emmanuel Caeymaex
Corporate Officer/Principal chez UCB
Profil
Emmanuel Caeymaex is currently the Executive VP & Head-Immunology Solutions at UCB SA. Previously, he worked as the Director at Dermira, Inc. in 2017 and as the President at UCB Japan Co. Ltd.
from 2006 to 2011.
He holds a graduate degree from Université Catholique de Louvain and CEMS The Global Alliance in Management Education.
Postes actifs de Emmanuel Caeymaex
| Sociétés | Poste | Début |
|---|---|---|
| UCB | Corporate Officer/Principal | 01/03/1994 |
Anciens postes connus de Emmanuel Caeymaex
| Sociétés | Poste | Fin |
|---|---|---|
| DERMIRA, INC. | Director/Board Member | 06/11/2017 |
| UCB Japan Co. Ltd. | President | 01/06/2011 |
Formation de Emmanuel Caeymaex
| Université Catholique de Louvain | Graduate Degree |
| CEMS The Global Alliance in Management Education | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| UCB | Health Technology |
| Entreprise privées | 2 |
|---|---|
| UCB Japan Co. Ltd. | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
